• 1. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 2. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 3. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 4. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone (CAS No. 36804-11-2)

1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone, identified by its Chemical Abstracts Service (CAS) number 36804-11-2, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to the class of phenylketones, which are widely recognized for their diverse biological activities and potential applications in drug development. The unique structural features of 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone, particularly its trisubstituted phenyl ring system, contribute to its distinct chemical properties and make it a valuable scaffold for medicinal chemistry investigations.

The synthesis and characterization of 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone have been extensively studied due to its potential role as an intermediate in the preparation of more complex molecules. The methoxymethoxy substituents on the phenyl ring introduce both steric hindrance and electronic effects that can modulate the reactivity and binding affinity of the compound. These features make it an attractive candidate for further functionalization and derivatization, enabling the exploration of novel pharmacophores.

In recent years, there has been growing interest in phenylketones as bioactive molecules. Research has demonstrated that these compounds can exhibit a wide range of biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. The structural complexity of 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone suggests that it may possess unique interactions with biological targets, making it a promising candidate for therapeutic applications.

One of the most compelling aspects of 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone is its potential as a tool compound in chemical biology studies. Its well-defined structure allows researchers to investigate the effects of specific substituents on biological activity. This has led to several innovative approaches in drug discovery, where modifications to the phenyl ring system can be systematically explored to optimize potency and selectivity.

The latest advancements in computational chemistry have further enhanced the utility of 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone. Molecular modeling techniques have been employed to predict the binding modes of this compound with various biological targets. These predictions have provided valuable insights into its mechanism of action and have guided the design of more effective derivatives. The integration of experimental data with computational methods has significantly accelerated the drug discovery process.

Moreover, the synthesis of 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone has been optimized for scalability and efficiency. Modern synthetic methodologies have enabled the production of this compound in multi-kilogram quantities, making it more accessible for industrial applications. This advancement has opened up new possibilities for its use in pharmaceutical manufacturing and other chemical processes.

The pharmacological properties of 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone have been thoroughly evaluated in preclinical studies. These studies have revealed promising results regarding its potential therapeutic benefits. For instance, research has shown that this compound can modulate key signaling pathways involved in inflammation and cancer progression. Such findings have positioned 1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone as a lead compound for further development into novel therapeutics.

In conclusion,1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone (CAS No. 36804-11-2) is a versatile and highly interesting compound with significant potential in pharmaceutical research. Its unique structural features and diverse biological activities make it a valuable asset for drug discovery efforts. As research continues to uncover new applications for this compound,1-2,4,6-Tris(methoxymethoxy)phenyl-ethanone is poised to play a crucial role in the development of next-generation therapeutics.

• 832-58-6(2',4',6'-Trimethoxyacetophenone)
• 23121-32-6(Methylxanthoxylin)
• 703-23-1(2-Hydroxy-6-methoxyacetophenone)
• 3602-54-8(2,4-Dihydroxy-6-methoxyacetophenone)
• 2040-04-2(2',6'-Dimethoxyacetophenone)
• 829-20-9(2',4'-Dimethoxyacetophenone)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)